Movatterモバイル変換


[0]ホーム

URL:


Nam et al., 2015 - Google Patents

Biomimetic 3D tissue models for advanced high-throughput drug screening

Nam et al., 2015

ViewHTML @Full View
Document ID
16455194971948780669
Author
Nam K
Smith A
Lone S
Kwon S
Kim D
Publication year
Publication venue
Journal of laboratory automation

External Links

Snippet

Most current drug screening assays used to identify new drug candidates are 2D cell-based systems, even though such in vitro assays do not adequately re-create the in vivo complexity of 3D tissues. Inadequate representation of the human tissue environment during a …
Continue reading atjournals.sagepub.com (HTML) (other versions)

Classifications

The classifications are assigned by a computer and are not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
    • C12N5/0602Vertebrate cells
    • C12N5/067Hepatocytes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells

Similar Documents

PublicationPublication DateTitle
Nam et al.Biomimetic 3D tissue models for advanced high-throughput drug screening
Park et al.Applications of biomaterials in 3D cell culture and contributions of 3D cell culture to drug development and basic biomedical research
Singh et al.3D printing of scaffold for cells delivery: advances in skin tissue engineering
Valdoz et al.The ECM: to scaffold, or not to scaffold, that is the question
Randall et al.Advances in the Biofabrication of 3D Skin in vitro: Healthy and Pathological Models
Janani et al.Mimicking native liver lobule microarchitecture in vitro with parenchymal and non-parenchymal cells using 3D bioprinting for drug toxicity and drug screening applications
Sacchi et al.Bioengineered 3D models to recapitulate tissue fibrosis
Kook et al.Design of biomimetic cellular scaffolds for co-culture system and their application
Mohammadi et al.Skin diseases modeling using combined tissue engineering and microfluidic technologies
Klicks et al.In vitro skin three-dimensional models and their applications
Kang et al.Advances and innovations of 3D bioprinting skin
Correia Carreira et al.3D bioprinting: the emergence of programmable biodesign
Nimiritsky et al.Unveiling mesenchymal stromal cells’ organizing function in regeneration
Park et al.3D miniaturization of human organs for drug discovery
Wang et al.Optimizing the fabrication processes for manufacturing a hybrid hierarchical polyurethane–cell/hydrogel construct
Vajda et al.Microvascular tissue engineering—A review
Hauser et al.Bioprinting scaffolds for vascular tissues and tissue vascularization
Soto-Gutierrez et al.Cell delivery: from cell transplantation to organ engineering
Zhe et al.Recent advances in decellularized extracellular matrix-based bioinks for 3D bioprinting in tissue engineering
Parihar et al.3D printed human organoids: High throughput system for drug screening and testing in current COVID‐19 pandemic
Strobel et al.Vascularized tissue organoids
Klak et al.Novel strategies in artificial organ development: what is the future of medicine?
Miyamoto et al.Spheroid formation and evaluation of hepatic cells in a three-dimensional culture device
Afflerbach et al.Mesenchymal stem cells as a promising cell source for integration in novel in vitro models
Romagnoli et al.Available in vitro models for human satellite cells from skeletal muscle

[8]
ページ先頭

©2009-2025 Movatter.jp